BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025


Werte in diesem Artikel
Aktien

34.40 EUR 0.20 EUR 0.58 %

BOTHELL, Wash., Nov. 17, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, today announced that management will participate in the following investor conferences during November and December:

BioLife Solutions Logo (PRNewsfoto/BioLife Solutions, Inc.)

  • Raymond James Napa Small Cap Symposium
    • November 17, 2025
    • Napa Valley at The Meritage
  • Stephens Annual Investment Conference
    • November 18-20, 2025
    • Nashville at the Grand Hyatt Nashville
  • Jefferies Global Healthcare Conference
    • November 17-20, 2025
    • London at The Waldorf Hilton
  • Furey Research Partners Hidden Gems Conference
    • November 24-25, 2025
    • Virtual
  • Wolfe Research Small & Mid-Cap Conference
    • December 2-3, 2025
    • Virtual
  • Northland Growth Conference 2025
    • December 16, 2025
    • Virtual

The BioLife Solutions Investor Presentation, reflecting the recently refreshed corporate branding, is now available on the Investor Relations section of the company's website.

About BioLife Solutions

BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com

Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
jcain@allianceadvisors.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-participate-in-upcoming-investor-conferences-in-november-and-december-2025-302617059.html

SOURCE BioLife Solutions, Inc.

Aktuelle Biolife Solutions Aktie News

Werbung

Biolife Solutions Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Biolife Solutions nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
Datum Rating Analyst
22.07.19 Biolife Solutions Buy H.C. Wainwright & Co.
10.11.17 Biolife Solutions Buy Maxim Group
19.09.17 Biolife Solutions Buy Maxim Group
10.03.17 Biolife Solutions Buy Maxim Group
19.01.17 Biolife Solutions Buy Maxim Group

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.